Skip to main content

Jason Mills

Stock Analyst at Canaccord Genuity

Total Price Targets
3
Stocks Covered
2
Sectors
Healthcare
Most Recent
Oct 30, 2025

Notable Calls (Last 12 Months)

Most Bullish

  • TMDX+9.4%
    TransMedics Group, Inc.
    $147.00 targetOct 30, 2025

Most Bearish

  • TMDX+9.4%
    TransMedics Group, Inc.
    $147.00 targetOct 30, 2025

Stocks Covered by Jason Mills

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
TMDXTransMedics Group, Inc.$147.00$100.16+46.8%2Oct 30, 2025
PENPenumbra, Inc.$235.00$325.86-27.9%1Oct 16, 2024

Recent Activity

  • Oct 30, 2025— Set$147.00price target onTMDX(TransMedics Group, Inc.)
  • Oct 29, 2024— Set$109.00price target onTMDX(TransMedics Group, Inc.)
  • Oct 16, 2024— Set$235.00price target onPEN(Penumbra, Inc.)

Frequently Asked Questions

Who is Jason Mills?

Jason Mills is a stock analyst at Canaccord Genuity covering 2 stocks primarily in Healthcare. They have issued 3 price targets since Oct 16, 2024.

What stocks does Jason Mills cover?

Jason Mills currently covers 2 stocks, including TMDX, PEN.

What is Jason Mills's latest price target?

Jason Mills's most recent price target was $147.00 on TMDX (TransMedics Group, Inc.), set on Oct 30, 2025.

What is Jason Mills's highest price target?

Jason Mills's highest issued price target is $235.00 on PEN, set on Oct 16, 2024.

More Analysts at Canaccord Genuity

Maria Ripps
Canaccord Genuity
Targets48
Stocks18
Joseph Vafi
Canaccord Genuity
Targets43
Stocks18
Brian McNamara
Canaccord Genuity
Targets38
Stocks16
Austin Moeller
Canaccord Genuity
Targets38
Stocks17

Coverage based on publicly published price targets. Not investment advice.